Jonathon Cohen, MD, MS, interprets long-term safety and efficacy data for ibrutinib as studied in relapsed mantle cell lymphoma.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
![](https://i.ytimg.com/vi/z2dM7tvvF1E/maxresdefault.jpg)
Jonathon Cohen, MD, MS, interprets long-term safety and efficacy data for ibrutinib as studied in relapsed mantle cell lymphoma.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]